145 related articles for article (PubMed ID: 32274275)
1. Promyelocytic Blast Crisis of Chronic Myeloid Leukemia in a Patient Undergoing Therapy with a Tyrosine Kinase Inhibitor.
Parsi M; Budak-Alpdogan T
Cureus; 2020 Mar; 12(3):e7217. PubMed ID: 32274275
[TBL] [Abstract][Full Text] [Related]
2. All-
Colvin TA; Vachhani P; Sait S; Neppalli V; Wang ES
Leuk Res Rep; 2018; 10():16-19. PubMed ID: 30090695
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract][Full Text] [Related]
4. Promyelocytic blast crisis of chronic myeloid leukemia during imatinib treatment.
Chung HJ; Chi HS; Cho YU; Park CJ; Seo EJ; Kim KH; Lee JH
Ann Clin Lab Sci; 2008; 38(3):283-6. PubMed ID: 18715859
[TBL] [Abstract][Full Text] [Related]
5. Interstitial insertion of retinoic acid receptor-alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17.
Hiorns LR; Min T; Swansbury GJ; Zelent A; Dyer MJ; Catovsky D
Blood; 1994 May; 83(10):2946-51. PubMed ID: 8180390
[TBL] [Abstract][Full Text] [Related]
6. AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia.
Fatima M; Kakar SJ; Adnan F; Khan K; Mian AA; Khan D
BMC Cancer; 2021 Jun; 21(1):713. PubMed ID: 34140003
[TBL] [Abstract][Full Text] [Related]
7.
Wolanin S; McCall RK; Pettenati MJ; Beaty MW; Insuasti-Beltran G; Powell BL; O'Neill SS
Case Rep Hematol; 2020; 2020():8830595. PubMed ID: 32953185
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of p210
Wang YY; Ding WJ; Jiang F; Chen ZX; Cen JN; Qi XF; Liang JY; Liu DD; Pan JL; Chen SN
Oncol Lett; 2017 Nov; 14(5):5171-5178. PubMed ID: 29151902
[TBL] [Abstract][Full Text] [Related]
9. Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report.
Lee MH; Song A; Li JY
Diagn Pathol; 2024 Jan; 19(1):21. PubMed ID: 38268039
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic blast crisis of chronic myelogenous leukemia. A rare subtype associated with disseminated intravascular coagulation.
Rosenthal NS; Knapp D; Farhi DC
Am J Clin Pathol; 1995 Feb; 103(2):185-8. PubMed ID: 7856560
[TBL] [Abstract][Full Text] [Related]
11. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic blast crisis of chronic myelogenous leukaemia with translocations (9;22) and (15;17).
Scolnik MP; Palacios MF; Acevedo SH; Castuma MV; Larripa IB; Palumbo A; Moiraghi EB; Sasot AM; Huberman AB
Leuk Lymphoma; 1998 Sep; 31(1-2):231-6. PubMed ID: 9720733
[TBL] [Abstract][Full Text] [Related]
13. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
Chen SJ; Chen LJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
[TBL] [Abstract][Full Text] [Related]
14. Triptolide induces cell death independent of cellular responses to imatinib in blast crisis chronic myelogenous leukemia cells including quiescent CD34+ primitive progenitor cells.
Mak DH; Schober WD; Chen W; Konopleva M; Cortes J; Kantarjian HM; Andreeff M; Carter BZ
Mol Cancer Ther; 2009 Sep; 8(9):2509-16. PubMed ID: 19723894
[TBL] [Abstract][Full Text] [Related]
15. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
16. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K
Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal abnormality of acute promyelocytic leukemia other than
Imataki O; Uemura M
BMC Clin Pathol; 2016; 16():16. PubMed ID: 27708545
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
[TBL] [Abstract][Full Text] [Related]
19. Blockade of deubiquitinase YOD1 degrades oncogenic PML/RAR
Shao X; Chen Y; Wang W; Du W; Zhang X; Cai M; Bing S; Cao J; Xu X; Yang B; He Q; Ying M
Acta Pharm Sin B; 2022 Apr; 12(4):1856-1870. PubMed ID: 35847510
[TBL] [Abstract][Full Text] [Related]
20. Bi-lineage B- and T-lymphoid Extramedullary Blast Crisis at an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review of Extramedullary Blast Crisis.
Benlachgar N; Masrar A; Haidouri S; Harmouche H; Tazi Mezalek Z
Cureus; 2023 Nov; 15(11):e49348. PubMed ID: 38143593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
